DRD2-related TaqIA polymorphism modulates motivation to smoke

Nicotine and Tobacco Research

Volumn 11, Issue 11, 2009, Pages 1321-1329

  Zuo, Yantao ^a,c   Gilbert, David G ^a   Rabinovich, Norka E ^a   Riise, Hege ^a   Needham, Rachel ^a,b   Huggenvik, Jodi I ^b  

^a SOUTHERN ILLINOIS UNIVERSITY   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR;

ALLELE; ARTICLE; COGNITION; DNA POLYMORPHISM; DOPAMINERGIC TRANSMISSION; FEMALE; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATION; PRIORITY JOURNAL; SELF REPORT; SEX DIFFERENCE; SMOKING; SMOKING CESSATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; QUESTIONNAIRE;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MOTIVATION; POLYMORPHISM, GENETIC; QUESTIONNAIRES; RECEPTORS, DOPAMINE D2; SMOKING;

EID: 74049103726     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntp141     Document Type: Article

References (65)

1. Berridge, K. C. (2007). The debate over dopamine's role in reward: The case for incentive salience. Psychopharmacology, 1 91, 391-431.
2. Brody, A. L. (2006). Functional brain imaging of tobacco use and dependence. Journal of Psychiatric Research, 40, 404-418.
3. Brody, A. L., Olmstead, R. E., London, E. D., Farahi, J., Meyer, J. H., Grossman, P., et al. (2004). Smoking-induced ventral striatum dopamine release. American Journal of Psychiatry, 161, 1211-1218.
4. Carter, B. L., & Tiffany, S. T. (2001). The cue-availability paradigm: The effects of cigarette availability on cue reactivity in smokers. Experimental and Clinical Psychopharmacology, 9, 183-190.
5. Cinciripini, P. M., Wetter, D. W., Tomlinson, G. E., Tsoh, J. Y., De Moor, C. A., Cinciripini, L. G., et al. (2004). The effects of the DRD2 polymorphism on smoking cessation and negative affect: Evidence for a pharmacogenetic effect on mood. Nicotine & Tobacco Research, 6, 229-239.
6. Clarke, P. B. S., Fu, D. S., Jakubovic, A., & Fibiger, H. C. (1988). Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. Journal of Pharmacology and Experimental Therapeutics, 246, 701-707.
7. Corrigall, W. A., & Coen, K. M. (1991). Selective dopamine antagonists reduce nicotine self-administration. Psychopharmacology, 104, 171-176.
8. Corrigall, W. A., Franklin, K. B., Coen, K. M., & Clarke, P. B. (1992). The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology, 107, 285-289.
9. David, S. P., Brown, R. A., Papandonatos, G. D., Kahler, C. W., Lloyd-Richardson, E. E., Munafò, M. R., et al. (2007). Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. Nicotine & Tobacco Research, 9, 821-823.
10. David, S. P., Niaura, R., Papandonatos, G. D., Shadel, W. G., Beerkholder, G. J., Britt, D. M., et al. (2003). Does the DRD2-Taq1 A polymorphism influence treatment response bupropion hydrochloride fir reduction of the nicotine withdrawal syndrome? Nicotine & Tobacco Research, 5, 925-942.
11. David, S. P., Strong, D. R., Munafò, M. R., Brown, R. A., Lloyd-Richards, E. E., Wileyt, P. E., et al. (2007). Bupropion efficacy for smoking cessation is influenced by the DRD2 TaqIA polymorphism: Analysis of pooled data from two clinical trials. Nicotine & Tobacco Research, 9, 1251-1257.
12. Di Chiara, G., & Imperato, A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proceedings of the National Academy of Sciences of United States of America, 85, 5274-5278.
13. Doherty, K., Kinnunen, T., Militello, F. S., & Garvey, A. G. (1995). Urges to smoke during the first month of abstinence: Relationship to relapse and predictors. Psychopharmacology, 119, 171-178.
14. Drummond, D. C. (2001). Theories of drug craving, ancient, and modern. Addiction, 96, 33-46.
15. Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998). Dramatic decrease in brain reward function during nicotine withdrawal. Nature, 393, 76-79.
16. Fehr, C., Yakushev, I., Hohmann, N., Buchholz, H., Landvogt, C., Deckers, H., et al. (2008). Association of low striatal dopamine D2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse. American Journal of Psychiatry, 165, 507-514.
17. Gilbert, D. G. (1995). Smoking: Individual differences, psychopathology, and emotion. Washington, DC: Taylor & Francis.
18. Gilbert, D. G., Crauthers, D. M., Mooney, D. K., & McClernon, F. J. (1999). Effects of monetary contingencies on smoking relapse: Influence of trait depression, personality, and habitual nicotine intake. Experimental and Clinical Psychopharmacology, 7, 1-8.
19. Gilbert, D. G., Izetelny, A., Radtke, R., Hammersley, J., Rabinovich, N. E., Jameson, T. R., et al. (2005). Dopamine receptor (DRD2) genotype-dependent effects of nicotine on attention and distraction during rapid visual information processing. Nicotine & Tobacco Research, 7, 361-379.
20. Gilbert, D. G., McClernon, F. J., Rabinovich, N. E., Sugai, C., Plath, L. C., Asgaard, G., et al. (2004). Effects of quitting smoking on EEG activation and attention last for more than 31 days and are more severe with stress, dependence, DRD2 A1 allele, and depressive traits. Nicotine & Tobacco Research, 6, 249-267.
21. Gilbert, D. G., Sharpe, J. P., Ramanaiah, N. V., Detwiler, F. R. J., & Anderson, A. E. (2000). Development of a situation × trait adaptive response (STAR) model-based smoking motivation questionnaire. Personality and Individual Differences, 29, 65-84.
22. Gilbert, D. G., Zuo, Y., Rabinovich, N. E., Riise, H., Needham, R., & Huggenvik, J. I. (2009). Neurotransmission-related genetic polymorphisms, negative affectivity traits, and gender predict tobacco abstinence symptoms across 44 days with and without nicotine patch. Journal of Abnormal Psychology, 118, 322-334.
23. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerström, K. O. (1991). The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction, 86, 1119-1127.
24. Horn, D., & Waingrow, S. (1966). Behavior and attitudes questionnaires. Bethesda, MD: National Clearinghouse for Smoking and Health.
25. Hughes, J. R., Gust, S. W., Skoog, K., Keenan, R. M., & Fenwick, J. W. (1991). Symptoms of tobacco withdrawal: A replication and extension. Archives of General Psychiatry, 48, 52-59.
26. Iwamoto, E. T. (1984). An assessment of the spontaneous activity of rats administered morphine, phencyclidine, or nicotine using automated and observational methods. Psychopharmacology, 84, 374-382.
27. Jentsch, J. D., & Taylor, J. R. (1999). Impulsivity resulting from frontostriatal dysfunction in drug abuse: Implications for the control of behavior by reward-related stimuli. Psychopharmacology, 146, 373-390.
28. Joffe, R., Lowe, M. R., & Fisher, E. B., Jr. (1981). A validity test of the reasons for smoking scale. Addictive Behavior, 6, 41-45.
29. Killen, J. D., & Fortmann, S. P. (1997). Craving is associated with smoke relapse: Findings from three prospective studies. Experimental and Clinical Psychopharmacology, 5, 137-142.
30. Koob, G. F., & Le Moal, M. (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology, 24, 97-129.
31. Levin, E. D., McClernon, F. J., & Rezvani, A. H. (2006). Nicotinic effects on cognitive function: Behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology, 184, 523-539.
32. Levin, E. D., & Simon, B. B. (1998). Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology, 138, 217-230.
33. Markou, A., Kosten, T. R., & Koob, G. F. (1998). Neurobiological similarities in depression and drug dependence: A self medication hypothesis. Neuropsychopharmacology, 18, 135-174.
34. Maskos, U., Molles, B. E., Pons, S., Besson, M., Guiard, B ., Guilloux, J. P., et al. (2005). Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature, 436, 103-107.
35. McBride, D., Barrett, S. P., Kelly, J. T., Aw, A., & Dagher, A. (2006). Effects of expectancy and abstinence on the neural response to smoking cues in cigarette smokers: An fMRI study. Neuropsychopharmacology, 31, 2728-2738.
36. Munafò, M. R., Clark, T. G., Johnstone, E. C., Murphy, M. F. G., & Walton, R. (2004). Genetic polymorphisms and smoking behaviour: A systematic review and meta-analysis. Nicotine & Tobacco Research, 6, 583-597.
37. Munafò, M. R., Johnstone, E. C., Murphy, M. F. G., & Aveyard, P. (2009). Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial. Nicotine & Tobacco Research, 11, 404-407.
38. Munafò, M. R., Timpson, N. J., David, S. P., Ebrahim, S., & Lawlor, D. A. (2009). Association of the DRD2 gene Taq1A polymorphism and smoking behavior: A meta-analysis and new data. Nicotine & Tobacco Research, 11, 64-76.
39. Munro, C. A., McCaul, M. E., Wong, D. F., Oswald, L. M., Zhou, Y., Brasic, J., et al. (2006). Sex differences in striatal dopamine release in healthy adults. Biological Psychiatry, 59, 966-974.
40. Neville, M. J., Johnstone, E. C., & Walton, R. T. (2004). Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Human Mutation, 23, 540-545.
41. Nisell, M., Nomikos, G. G., & Svensson, T. H. (1994). Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse, 16, 36-44.
42. Noble, E. P., Blum, K., Ritchie, T., Montgomery, A., & Sheridan, P. J. (1991). Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Archives of General Psychiatry, 48, 648-654.
43. Park, E. (2009). Gender as a moderator in the association of body weight to smoking and mental health. American Journal of Public Health, 99, 146-151.
44. Perkins, K. A., Lerman, C., Grottenthaler, A., Ciccocioppo, M. M., Milanak, M., Conklin, C. A ., et al. (2008). Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood. Behavioural Pharmacology, 19, 641-649.
45. Pomerleau, O. F. (1986). Nicotine as a psychoactive drug: Anxiety and pain reduction. Psychopharmacology Bulletin, 22, 865-869.
46. Potter, B. K., Pederson, L. L., Chan, S. S., Aubult, J. A., & Koval, J. J. (2004). Does a relationship exist between body weight, concerns about weight, and smoking among adolescents? An integration of the literature with an emphasis on gender. Nicotine & Tobacco Research, 6, 397-425.
47. Raudenbush, S. W., & Bryk, A. S. (2002). Hierarchical linear models: Applications and data analysis method (2nd ed.). Newbury Park, CA: Sage.
48. Ritchie, T., & Noble, E. P. (2003). Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochemical Research, 28, 73-82.
49. Robinson, T. E., & Berridge, K. C. (1993). The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Research Reviews, 18, 247-291.
50. Schoffelmeer, A. N., De Vries, T. J., Wardeh, G., van de Ven, H. W., & Vanderschuren, L. J. (2002). Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation. Journal of Neuroscience, 22, 3269-3276.
51. Shiffman, S. (1979). The tobacco withdrawal syndrome. In N. A. Krasnegor (Ed.), Cigarette smoking as a dependence process (NIDA Research Monograph 23, pp. 153-184). Rockville, MD: Public Health Service.
52. Shiffman, S., Engberg, J. B., Paty, J. A., Perz, W. G., Gnys, M., Kassel, J. D., et al. (1997). A day at a time: Predicting smoking lapse from daily urges. Journal of Abnormal Psychology, 106, 104-116.
53. Shiffman, S., & Ferguson, S. G. (2008). The effect of a nicotine patch on cigarette craving over the course of the day: Results from two randomized clinical trials. Current Medical Research and Opinion, 24, 2795-2804.
54. Shiffman, S., & Waters, A. J. (2004). Negative affect and smoking lapses: A prospective analysis. Journal of Consulting and Clinical Psychology, 72, 192-201.
55. Stein, E. A., Pankiewicz, J., Harsch, H. H., Cho, J.-K., Fuller, S. A., Hoffman, R. G ., et al. (1998). Nicotine-induced limbic cortical activation in the human brain: A functional MRI study. American Journal of Psychiatry, 155, 1009-1015.
56. Tate, J. C., & Stanton, A. L. (1990). Assessment of the validity of the reasons for smoking scale. Addictive Behavior, 15, 129-135.
57. Tiffany, S. T., Cox, L. S., & Elash, C. A. (2000). Effects of transdermal nicotine patches on abstinence-induced and cue-elicited craving in cigarette smokers. Journal of Consulting and Clinical Psychology, 68, 233-240.
58. Transdermal Nicotine Study Group. (1991). Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. Journal of the American Medical Association, 266, 3133-3138.
59. Wang, Z., Faith, M., Patterson, F., Tang, K., Kerrin, K., Wileyto, E. P., et al. (2007). Neural substrates of abstinence-induced cigarette cravings in chronic smokers. Journal of Neuroscience, 27, 14035-14040.
60. Wesnes, K., & Warburton, D. M. (1983). Effects of smoking on rapid visual information processing. Neuropsychobiology, 9, 223-229.
61. Wilson, S. J., Sayette, M. A., Delgado, M. R., & Fiez, J. A. (2005). Instructed smoking expectancy modulates cue-elicited neural activity: A preliminary study. Nicotine & Tobacco Research, 7, 637-645.
62. Wise, R. A. (1988). The neurobiology of craving: Implications for the understanding and treatment of addiction. Journal of Abnormal Psychology, 97, 118-132.
63. Wise, R. A., & Bozarth, M. A. (1987). A psychomotor stimulant theory of addiction. Psychological Review, 94, 469-492.
64. Wise, R. A., & Rompré, P. P. (1989). Brain dopamine and reward. Annual Review of Psychology, 40, 191-225.
65. Yudkin, P., Munafò, M., Hey, K., Roberts, S., Welch, S., Johnstone, E., et al. (2004). Effectiveness of nicotine patches in relation to genotype in women versus men: Randomised controlled trial. British Medical Journal, 328, 989-990.